These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 28587642)

  • 1. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M; Liu B; Xiao J; Yang Y; Zhang Y
    Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of long non-coding RNA‚ÄĎassociated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma.
    Qiu M; Feng D; Zhang H; Xia W; Xu Y; Wang J; Dong G; Zhang Y; Yin R; Xu L
    Oncotarget; 2016 Mar; 7(13):16012-22. PubMed ID: 26918601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
    Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
    J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
    Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
    Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
    Hou J; Yao C
    Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis.
    Cao P; Li F; Xiao Y; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao Z; Wu D; Zhang L; Zhao B
    Dis Markers; 2022; 2022():5118444. PubMed ID: 35237359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
    Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
    Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.